Results 111 to 120 of about 16,731 (246)

Editorial: The Design of Molecular Tools in Relation to Prions and Their Biosafety

open access: yesFrontiers in Bioengineering and Biotechnology, 2021
Maria Lurdes Pinto   +3 more
doaj   +1 more source

Prion‐related diseases and anaesthesia [PDF]

open access: yesAnaesthesia, 2001
P R, Lowe, T, Engelhardt
openaire   +2 more sources

Chronic Wasting Disease management responses in North America: A public policy analysis

open access: yesWildlife Society Bulletin, EarlyView.
In this study we use the Multiple Streams Framework from public policy theory to assess the responses of wildlife management agencies in states and provinces with CWD‐positive cases in the United States and Canada to alleviate public concerns and manage the spread of this disease.
Kelly H. Dunning   +12 more
wiley   +1 more source

Infection control in the brain and the eye

open access: yesActa Ophthalmologica, EarlyView.
Abstract The Central Nervous System (CNS), comprising the brain and the eye, is considered to have a ‘privileged’ mechanism for dealing with immunological challenge (immune privilege, IP). CNS IP has been revealed through experiments using foreign protein antigens and cell and tissue alloantigens (grafts), but evidence for a role for IP in modulating ...
John V. Forrester   +2 more
wiley   +1 more source

Chronic Wasting Disease and Potential Transmission to Humans

open access: yesEmerging Infectious Diseases, 2004
Chronic wasting disease (CWD) of deer and elk is endemic in a tri-corner area of Colorado, Wyoming, and Nebraska, and new foci of CWD have been detected in other parts of the United States.
Ermias D. Belay   +5 more
doaj   +1 more source

Technology and Biological Weapons: Future Threats [PDF]

open access: yes, 2004
Ye
Davison, N., Millett, P., Nixdorff, K.
core  

Cellular Prion Protein Mediates Toxic Signaling of Amyloid Beta [PDF]

open access: yes, 2011
Prion diseases in humans and animals comprise a group of invariably fatal neurodegenerative diseases characterized by the formation of a pathogenic protein conformer designated PrPSc and infectious particles denoted prions.
Resenberger, Ulrike K.   +2 more
core   +1 more source

Inhibition of P53-related apoptosis had no effect on PrPSc accumulation and prion disease incubation time

open access: yesNeurobiology of Disease, 2005
Results from several laboratories indicate that apoptosis via the P53 pathway is involved in prion disease pathogenesis. Prion diseases, among them scrapie and BSE, are a group of fatal neurodegenerative disorders associated with the conversion of PrP(C) to PrP(Sc), its conformational abnormal isoform.
Roni Engelstein   +4 more
openaire   +3 more sources

Epilepsia partialis continua as the presenting manifestation of Creutzfeldt–Jakob disease: A video‐polygraphic clinical vignette

open access: yes
Epileptic Disorders, EarlyView.
Roberta Cutellè   +8 more
wiley   +1 more source

Red blood cell membrane proteome as a reporter of disease severity, transfusion impact and genetic background in transfusion‐dependent β‐thalassaemia

open access: yesBritish Journal of Haematology, EarlyView.
Summary Omics technologies have transformed research in haemoglobinopathies, yet the proteome of RBCs remains largely unexplored in transfusion‐dependent thalassaemia (TDT). In this proteomic analysis, Red blood cell (RBC) membranes from 48 adults with TDT were compared with healthy controls.
Konstantina Theocharaki   +8 more
wiley   +1 more source

Home - About - Disclaimer - Privacy